Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001658418 | SCV001871808 | likely benign | not provided | 2020-11-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002421231 | SCV002721803 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-05-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002539591 | SCV003033581 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-01-24 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004008956 | SCV004826822 | likely benign | Marfan syndrome | 2023-10-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004699440 | SCV005203214 | likely benign | not specified | 2024-07-08 | criteria provided, single submitter | clinical testing |